本页面由Tiger Trade Technology Pte. Ltd.提供服务

BriaCell Therapeutics Corp.

3.75
-0.1400-3.60%
盘后3.860.1100+2.93%19:40 EDT
成交量:31.25万
成交额:118.03万
市值:2,718.94万
市盈率:-0.19
高:4.00
开:3.90
低:3.72
收:3.89
52周最高:98.20
52周最低:3.60
股本:725.05万
流通股本:648.25万
量比:1.97
换手率:4.82%
股息:- -
股息率:- -
每股收益(TTM):-19.9792
每股收益(LYR):-62.1862
净资产收益率:-179.21%
总资产收益率:-89.44%
市净率:0.88
市盈率(LYR):-0.06

数据加载中...

2022/12/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/12/08

重要事件披露

8-K - Current report
2022/11/30

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/10/28

重要事件披露

8-K - Current report
2022/10/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/10/21

重要事件披露

8-K - Current report
2022/09/14

重要事件披露

8-K - Current report
2022/08/04

重要事件披露

8-K - Current report
2022/08/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/20

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/16

[修订]年度报告

40-F/A [Amend] - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2021/10/29

年度报告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]